Singota™ Solutions Announces Selection of Vanrx Aseptic Filling Equipment

Share Article

Singota, a contract service provider to the pharmaceutical industry, invests in state-of-the-art aseptic filling technology.

Vanrx Pharmasystems’s SA25 Aseptic Filling Workcell

Of particular benefit to our clients will be the SA25’s system configuration that is designed to reduce loss of scarce and expensive drug products during processing.

Singota Solutions has selected Vanrx Pharmasystems’s SA25 Aseptic Filling Workcell to provide the company’s new filling capability. Singota chose the Vanrx technology for its manufacturing flexibility and the exceptional drug product quality that it can deliver to pharmaceutical companies making injectable medicines.

The Vanrx system provides a completely automated filling process integrated within an isolator. The system is a gloveless, robotic workcell that performs filling, stoppering, and capping processes. Singota customers will benefit from highly repeatable, precision fills with reduced particulate counts versus conventional technology. Unique material handling features allow the versatility to fill vials, syringes, and cartridges.

Alisa Wright, CEO of Singota, commented, “Our clients are facing a market environment with increasing numbers of targeted therapies for smaller patient populations, pressure to shorten development lead times, and ever-increasing drug performance requirements. We have selected the Vanrx SA25 system with its state-of-the-art technology to give our clients a step change improvement in dealing with these complexities in the drug development business. Of particular benefit to our clients will be the SA25’s system configuration that is designed to reduce loss of scarce and expensive drug products during processing.”

Singota expects to take delivery of the equipment by the end of 2016, with an anticipated start of these services in 2017. The addition of small-scale, clinical aseptic manufacturing complements the company’s existing services that include formulation development, analytical testing, labeling and kitting, and supply chain management.

Chris Procyshyn, CEO of Vanrx, added, “We look forward to supporting Singota as they build a world-class aseptic filling operation. They will be able to take on the most advanced drug product filling challenges and become a critical link in their customers’ supply chains.”

About Singota Solutions

Singota is a cGMP compliant contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, labeling and kitting, and supply chain services. Headquartered in Bloomington, Indiana, Singota has over 50 employees with many years of valuable experience in the pharmaceutical and biotechnology industries. Singota Solutions is a dba of BioConvergence, LLC. For more information, visit http://www.singota.com.

About Vanrx Pharmasystems

Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies. For more information, visit http://www.vanrx.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Amy Osmond Cook

Amber Riley, Marketing Specialist
@OsmondMarketing
since: 04/2010
Follow >
Osmond Marketing
Like >
Osmond Marketing

Follow us on